Literature DB >> 32372760

Cytokine gene polymorphisms in type I and type II reactions in Hansen's disease.

Vijendran Pragasam1, Biju Vasudevan1, Nikhil Moorchung1.   

Abstract

INTRODUCTION: Leprosy or Hansen's disease is a chronic debilitating disease caused by Mycobacterium leprae. Host genetics are believed to strongly influence the course of the disease. It is known that cytokines play an important role in leprosy and cytokine gene polymorphisms probably influence the course of the disease.
METHODS: In the present study, we evaluated 70 patients with leprosy and 243 controls. DNA was extracted from the peripheral blood and genotyping was done for the following polymorphisms: IL-1 RA intron 2, IL-1β-511 C/T and TNF-α A/G.
RESULTS: A strong association of TNF-α-308 G/A polymorphism with Hansen's disease with both genotypes and alleles was found. However, no correlation was identified between the other two polymorphisms and Hansen's disease. A strong association between the IL-1β gene polymorphisms and the type of reactions seen in leprosy was found. In contrast, the other two polymorphisms did not show any such association. LIMITATIONS: Genetic polymorphisms are association studies. They are not a direct reflection of the transcriptome or proteome and this is a major limitation of this study.
CONCLUSION: In conclusion, cytokine gene polymorphisms appear to influence the susceptibility and course of Hansen's disease. An evaluation of the cytokine levels in the skin during lepra reactions would confirm this observation. Possibly, in future, this would be a guide to therapeutic decisions in cases of lepra reactions.

Entities:  

Keywords:  Cytokine gene polymorphisms; Hansen's disease; lepra reactions

Mesh:

Substances:

Year:  2020        PMID: 32372760     DOI: 10.4103/ijdvl.IJDVL_619_18

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  1 in total

1.  Hansen's disease in the era of COVID-19: An observation on a series of six patients with co-infection.

Authors:  Sandeep Arora; Anuj Bhatnagar; Gautam Kumar Singh; Reetika Pal; Amit Bahuguna; Pankaj Das; Prachi Verma
Journal:  Dermatol Ther       Date:  2021-02-04       Impact factor: 3.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.